Jacopo Leonardi

Jacopo is a proven global biopharmaceutical executive with a 25-year track record of creating sustainable growth for new ventures and underperforming franchises. He has deep expertise in multiple therapeutic areas including Orphan & Rare Diseases, Immunology, and Neurology and leading large teams in a range of functions including Strategy, Commercial Operations, R&D, Medical Affairs, Manufacturing, and Quality with a number of industry-leading biopharmaceutical companies, Eli Lilly, Johnson and Johnson, Baxter and Baxalta.

Prior to Agent Capital, Jacopo served on boards and in executive leadership across multiple companies in healthcare. As an Operating Partner at The Vistria Group, Jacopo was part of a team that acquired and helped accelerate the growth of AIS Healthcare, the nation’s leading 503A specialty pharmacy focused on targeted drug delivery and advanced infusion care in Neurology and Immunology. Jacopo serves as a Director on the AIS Board. Prior to his most recent healthcare ventures, Jacopo was Executive Vice President and President of Immunology for Baxalta where he led a fast growing $2.5B+ Global Division.

He was honored by the Healthcare Businesswomen’s Association (HBA) as the 2016 HBA Honorable Mentor of the Year for his dedication to the development and advancement of women in healthcare.

Jacopo received his MBA from Duke University’s Fuqua School of Business and Bachelor of Science from Rutgers College, where he was recognized as a Henry Rutgers Honors Scholar.